OTC
0.74USD
+0.01 (+0.80%)
We have scored 7 news catalysts on PetVivo Holdings, Inc. (PETV) over the past 12 months. The biggest single-day move next to one of them came Nov 25, 2025, when PETV closed −12.0%: “UPDATED: PetVivo AI, Inc. Launches AI Platform Reducing Veterinary Client Acquisition Costs by 50-90%”. Coverage across the window leans positive (average ticker sentiment +0.54). Most of the impact sits in forward growth expectations and short squeeze potential.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
27.9M
P/E
—
EPS
—
Beta
1.24
52W range
0.5899-1.69
Day range
0.72–0.79
Open
0.72
Prev close
0.74
Volume
4.9K
Avg volume
10.6K
Dividend
0.00
IPO
2014-09-08
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about PetVivo Holdings, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for PETV: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals. Its flagship product is Spryng, an intra-articular injection administered by veterinarians to effectively alleviate lameness and joint conditions, such as osteoarthritis, in canines and equines. The company's development pipeline further includes seventeen therapeutic devices poised for both veterinary and human clinical applications. Founded in 2009, PetVivo Holdings, Inc. maintains its corporate headquarters in Minneapolis, Minnesota.
